Cross Linking for Treatment of Corneal Infection

NCT00912509 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

30

Enrollment

INDUSTRY

Sponsor class

Stopped insufficient efficacy

Conditions

Infectious Keratitis

Interventions

DRUG: riboflavin
DEVICE: UVX Light

Sponsor

Price Vision Group

Collaborators

[object Object]